PLIANT THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20[•] Subordinated Debt SecuritiesIndenture • July 2nd, 2021 • Pliant Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [•], 20[•], among PLIANT THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
PLIANT THERAPEUTICS, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • July 2nd, 2021 • Pliant Therapeutics, Inc. • Pharmaceutical preparations • New York
Pliant Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
